4'-galactooligosaccharide has been researched along with mocetinostat in 1 studies
Studies (4'-galactooligosaccharide) | Trials (4'-galactooligosaccharide) | Recent Studies (post-2010) (4'-galactooligosaccharide) | Studies (mocetinostat) | Trials (mocetinostat) | Recent Studies (post-2010) (mocetinostat) |
---|---|---|---|---|---|
33 | 9 | 22 | 21,735 | 390 | 8,606 |
Protein | Taxonomy | 4'-galactooligosaccharide (IC50) | mocetinostat (IC50) |
---|---|---|---|
Histone deacetylase 3 | Homo sapiens (human) | 0.7851 | |
Nuclear receptor corepressor 1 | Homo sapiens (human) | 0.022 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.57 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.102 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 0.102 | |
Histone deacetylase 4 | Homo sapiens (human) | 0.5717 | |
Histone deacetylase 1 | Homo sapiens (human) | 0.3433 | |
Histone deacetylase 7 | Homo sapiens (human) | 0.6725 | |
Histone deacetylase 2 | Homo sapiens (human) | 0.3537 | |
Histone deacetylase 11 | Homo sapiens (human) | 0.6386 | |
Histone deacetylase 8 | Homo sapiens (human) | 0.6725 | |
Histone deacetylase 6 | Homo sapiens (human) | 0.5717 | |
Histone deacetylase 5 | Homo sapiens (human) | 0.6725 | |
Nuclear receptor corepressor 2 | Homo sapiens (human) | 0.045 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Eom, DH; Kim, JH; Park, HR; Shin, JC; Shin, KS; Shin, MS | 1 |
1 other study(ies) available for 4'-galactooligosaccharide and mocetinostat
Article | Year |
---|---|
Composition analysis and oral administered effects on dextran sulfate sodium-induced colitis of galactooligosaccharides bioconverted by Bacillus circulans.
Topics: Animals; Anti-Inflammatory Agents; Bacillus; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Inflammation Mediators; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Peroxidase; Prebiotics; Trisaccharides; Tumor Necrosis Factor-alpha | 2021 |